Expansion of the Recall
For mild, short-term conditions, self-care is often effective.
Rest and Hydration – Adequate sleep, fluids, and proper nutrition aid natural healing.
Over-the-Counter (OTC) Medications – Pain relievers, antihistamines, antacids, or topical creams can ease discomfort.
Lifestyle Adjustments – Regular exercise, balanced diet, and stress reduction techniques support general wellness.
Self-care is helpful, but if symptoms persist or worsen, professional care is the next step.
🎉 Participate in the Quiz & Win Prizes! 🎉
🏆 1st Prize: $20 Amazon Voucher
🥈 2nd Prize: $10 Amazon Voucher
📅 Winners will be announced on 31st August 2025.
💡 Your valuable time is precious to us. 💡
Don’t miss out—join the quiz and grab your chance to win! 🚀
Contamination Levels Detected
A pivotal concern driving this recall is the detection of Cs-137 in one sample of breaded shrimp tested by the FDA—not because of confirmed contamination in the U.S. food supply, but due to the risk of cross-contamination. While the detected level, approximately 68 Bq/kg, falls well below the FDA’s Derived Intervention Level of 1,200 Bq/kg—meaning it’s not an immediate hazard—it still poses a long-term risk if consumed repeatedly over time. The principal health risk lies in cumulative radiation exposure, which can damage DNA and potentially elevate cancer risk over time.
FDA Response and Import Alert
In response, the FDA has placed PT. Bahari Makmur Sejati (also known as BMS Foods), the Indonesian processor, under a stringent import alert for chemical contamination, effectively halting any of its shrimp from entering the U.S. market until the issue is resolved.
Consumer Warnings
Consumers are strongly urged to discard any recalled products immediately and refrain from eating, serving, or donating them. Retailers and distributors are likewise advised to remove and dispose of affected inventory and cooperate fully with FDA directives. Notably, no illnesses have been reported to date, reinforcing the FDA’s precautionary approach taken to safeguard public health.
Key Takeaways from the Recall
To summarize, the scope of this recall is broad and multifaceted:
Origin: PT. Bahari Makmur Sejati (BMS Foods), Indonesia
Contaminant: Cesium-137 (Cs-137), detected in one breaded shrimp sample
Initial Recall: Great Value shrimp at Walmart across ~13 states (late July–early August)
Expanded Recall: Southwind Foods-branded products (Sand Bar, Best Yet, Great American, Arctic Shores, First Street), distributed in nine states between July 17–August 8
FDA Actions: Import alert, recall advisories, ongoing supply-chain tracing
Consumer Guidance: Discard recalled products, avoid consumption, seek refunds where applicable
Health Risks: Long-term exposure to low-level Cs-137 may elevate cancer risk, though no acute threat or illnesses have emerged
Broader Implications
This extensive recall underscores the FDA’s commitment to preemptively tackling contamination—even in the absence of confirmed exposure—to protect consumers. It also highlights the challenges of ensuring food safety in global supply chains, particularly when products are sourced internationally and shipped in bulk to U.S. retailers.
Our Products
-
Hydroxychloroquine 200MG
$1.00 / Per Pill
-
Lisinopril 20mg
$1.00 / Per Pill
-
Gabapentin 300mg
$1.00 / Per Pill
